Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

SAD Phase I Study (First-in-human) to Investigate Contraloid Acetate

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03944460
Recruitment Status : Completed
First Posted : May 9, 2019
Last Update Posted : May 9, 2019
Sponsor:
Collaborators:
Helmholtz-Gemeinschaft Deutscher Forschungszentren, Germany
Medical University of Vienna
NeuroScios, Austria
Triskelion, The Netherlands
Fundación Teófilo Hernando, Spain
Information provided by (Responsible Party):
Prof. Dr. Dieter Willbold, Forschungszentrum Juelich

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 27, 2018
  Actual Study Completion Date : July 27, 2018